Autolus Therapeutics (AUTL) Interest & Investment Income (2017 - 2025)
Autolus Therapeutics posted quarterly Interest & Investment Income of $3.2 million for Q4 2025, down 56.67% year-on-year from $7.4 million in Q4 2024, and down 26.36% on a QoQ basis from $4.4 million in Q3 2025.
Autolus Therapeutics (AUTL) has 9 years of Interest & Investment Income data on file, last reported at $3.2 million in Q4 2025.
- For the quarter ending Q4 2025, Interest & Investment Income fell 56.67% year-over-year to $3.2 million; the trailing twelve-month figure through Dec 2025 stood at $19.0 million (down 41.34% YoY), and the FY2025 full-year result was $19.0 million, down 41.34% from the prior year.
- Interest & Investment Income for Q4 2025 stood at $3.2 million, down from $4.4 million in the prior quarter.
- Across five years, Interest & Investment Income topped out at $28.0 million in Q3 2021 and bottomed at $28000.0 in Q1 2022.
- The 5-year median for Interest & Investment Income is $3.4 million (2023), against an average of $4.7 million.
- The widest annual swing landed in 2021, when Interest & Investment Income surged 75575.68%; it then sank 99.41% in 2022.
- A 5-year view of Interest & Investment Income shows it stood at $149000.0 in 2021, then jumped by 857.05% to $1.4 million in 2022, then soared by 111.08% to $3.0 million in 2023, then jumped by 147.41% to $7.4 million in 2024, then plunged by 56.67% to $3.2 million in 2025.
- The last three Interest & Investment Income figures came in at $3.2 million (Q4 2025), $4.4 million (Q3 2025), and $5.2 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | - |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | 7.90 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 114.80 Mn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | - |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | 305,000.00 |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 26.60 Mn |
| 10 | Autolus Therapeutics | - | - | -1.04 Mn | 3.23 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 3.23 Mn |
| Sep 30, 2025 | 4.38 Mn |
| Jun 30, 2025 | 5.23 Mn |
| Mar 31, 2025 | 6.14 Mn |
| Dec 31, 2024 | 7.45 Mn |
| Sep 30, 2024 | 8.32 Mn |
| Jun 30, 2024 | 9.66 Mn |
| Mar 31, 2024 | 6.93 Mn |
| Dec 31, 2023 | 3.01 Mn |
| Sep 30, 2023 | 3.65 Mn |
| Jun 30, 2023 | 3.40 Mn |
| Mar 31, 2023 | 3.45 Mn |
| Dec 31, 2022 | 1.43 Mn |
| Sep 30, 2022 | 165,000.00 |
| Jun 30, 2022 | 89,000.00 |
| Mar 31, 2022 | 28,000.00 |
| Dec 31, 2021 | 149,000.00 |
| Sep 30, 2021 | 28.00 Mn |
| Jun 30, 2021 | 42,000.00 |
| Mar 31, 2021 | 44,000.00 |
| Dec 31, 2020 | 36,000.00 |
| Sep 30, 2020 | 37,000.00 |
| Mar 31, 2020 | 510,000.00 |
| Jun 30, 2019 | 1.07 Mn |
| Mar 31, 2019 | 541,000.00 |
| Sep 30, 2018 | 796,000.00 |
| Jun 30, 2018 | 266,000.00 |
| Mar 31, 2018 | 289,000.00 |
| Dec 31, 2017 | 181,000.00 |